QA: Regulus Therapeutics Inc in us_pharma/2024

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001505512_2025_Regulus_Therapeutics_Inc.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001505512, Regulus Therapeutics Inc

  xvar xval
0 AssetsCurrent 82,345,000
1 IntangibleAssetsNetIncludingGoodwill 25,000
2 PropertyPlantAndEquipmentNet 937,000
3 remainder_Assets 874,000
4 LiabilitiesCurrent 7,499,000
5 LiabilitiesNoncurrent 274,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 18,650,309
9 ResearchAndDevelopmentExpense 54,093,840
10 remainder_Expenses -195,284
11 remainder_Revenues 3,245,693
12 remainder_NetIncome 0
13 remainder_ComprehensiveNetIncome 29,073
  yvar yval
0 Assets 84,181,000
1 Liabilities 7,773,000
2 Expenses 72,548,865
3 Revenues 3,245,693
4 StockholdersEquity 76,408,000
5 NetIncome -69,303,172
6 ComprehensiveNetIncome -69,288,636
7 BaseVar 83,888,816
8 EconomicCapitalRatiobeforeLimitedLiability 2.12
9 EconomicCapitalRatio 3.10

Edgar->Model Mapping

Feature Distribution

Change over Time